Search
for
Sort by
Research 781–810 of 1000+
- RESPOSTA TERAPÊUTICA DA ALOPÉCIA ANDROGENÉTICA APÓS DRUG DELIVERY DIGITAL COM APLICAÇÃO DE PRODEW 500®, NANOFACTOR® AFGF, NANOFACTOR® VEGF, COPPER PEPTÍDEO®, PROHAIRIN B4®, CAPILLISIL HC® E ARCT-ALG®
- Antibody Drug Conjugates
- Transfollicular Drug Delivery Systems
- Epilepsy drug may also treat baldness
- Formulation development of drug nanocrystals and nanoparticles for dermal delivery
- Development of polymeric nanoparticles with controlled drug release for dermal application
- Erlotinib-related Severe Hair Loss with Severe Exanthematous Drug Eruption: A Case Report
- Old drug new indication: Tofacitinib for a new crop of hair?
- Arthritis drug spurs hair regrowth in alopecia patient
- P62 Drug induced hypothyroidism in patients receiving treatment for multi-drug resistant tuberculosis
- Faculty Opinions recommendation of Solitary fixed drug eruption caused by finasteride.
- Cutaneous Drug Reaction Case Reports
- Hair Drug Testing Routine in Many Clinical and Forensic Applications
- [Adverse drug reactions on hair].
- Physician-Drug Company Complex
- Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model
- Psoriasiform drug eruption to finasteride: Uncommon side effect of a commonly used drug
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- DrugNet: Network-based drug–disease prioritization by integrating heterogeneous data
- Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: A retrospective cohort study from Taiwan
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- FGF Family: From Drug Development to Clinical Application
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Hair analysis for veterinary drug monitoring in livestock production
- Investigation of drug partition property in artificial sebum
- Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin Therapy
- Psychotropic Medication and Drug-Related Alopecia
- High-content drug screening for rare diseases
- Advanced chemical imaging and comparison of human and porcine hair follicles for drug delivery by confocal Raman microscopy
- Roles of existing drug and drug targets for COVID-19 management